CIK 0001936258 · Large accelerated filer
NewAmsterdam Pharma Co N.V.
Sign in to watch- Ticker
- NAMS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- Netherlands
- Entity type
- operating
- Phone
- 35 206 2971
- Business address
- GOOIMEER 2-35, NARRDEN, Netherlands, 1411 DC
- Former names
- NewAmsterdam Pharma Co B.V.
Securities
- NAMS Ordinary Shares Nasdaq
- NAMSW Warrant Nasdaq
- 4 Option exercise Director acquired 3,102 shares (option exercise)
- 4 Grant or award Chief Scientific Officer acquired 19,302 shares (grant or award)
- 4 Open-market sale Chief Operating Officer sold 16,539 shares
- 4 Open-market sale Chief Executive Officer sold 12,258 shares
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 4 Option exercise Chief Scientific Officer acquired 150,000 shares (option exercise)
- 4 Planned sale Chief Operating Officer sold 100,000 shares
- EFFECT Other Notice of Effectiveness
- 424B3 Offering Prospectus
- 4 Open-market buy Director bought 4,005 shares at $21.02 ($84,203)
- CORRESP Other Correspondence Between Filers and SEC Staff
- 4 Open-market sale Chief Accounting Officer sold 150,000 shares at $20.37 ($3,055,500)
- 144 Insider Sale of Securities
- UPLOAD Other SEC-generated Letter
- S-3 Offering Registration Statement
- 10-K Report Annual Report
- 8-K Event Results of operations
- 4 Planned sale Chief Operating Officer sold 100,000 shares
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
Page 8 of 21 · 415 filings